Litcius/Paper detail

Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology

Juergen Prattes, Joost Wauters, Daniele Roberto Giacobbe, Jon Salmanton‐García, Johan Maertens, Marc Bourgeois, Marijke Reynders, Lynn Rutsaert, Niels Van Regenmortel, Piet Lormans, Simon Feys, Alexander C. Reisinger, Oliver A. Cornely, Tobias Lahmer, Maricela Valerio, Laurence Delhaès, Kauser Jabeen, Joerg Steinmann, Mathilde Chamula, Matteo Bassetti, Stefan Hatzl, Riina Rautemaa‐Richardson, Philipp Koehler, Katrien Lagrou, Martin Hoenigl, Yves Debaveye, Marisa H. Miceli, Jean‐Jacques Tudesq, Gregor Paul, Robert Krause, Marina Linhofer, Jonas Frost, Peter Zechner, Matthias Kochanek, Philipp Eller, Jeffrey D. Jenks, Sara Volpi, Anne‐Pauline Bellanger, P. Lewis White, Gustavo H. Goldman, Paul Bowyer, Antonis Rokas, Sara Gago, Paolo Pelosi, Chiara Robba, Jean‐Pierre Gangneux, Cornelia Lass-Floerl, Marina Machado, Patricia Muñóz

2021Clinical Microbiology and Infection230 citationsDOIOpen Access PDF

Topics & Concepts

MedicineEpidemiologyHazard ratioInternal medicineIntensive careAspergillosisPediatricsSurgeryIntensive care medicineImmunologyConfidence intervalAntifungal resistance and susceptibilityInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisOtolaryngology and Infectious Diseases